Stefania Gori, Alberto Zambelli, Catia Angiolini, Antonella Ferro, Fiorenza De Rose, Alessandra Fabi, Giuseppe Azzarello, Giuseppe Bogina, Maurizio Cancian, Matteo Valerio, Michela Cinquini, Fabrizio Nicolis, Giovanni Pappagallo
(2024).
Follow-up of breast cancer: why is it necessary to start a Consensus in 2024?.
AboutOpen.
Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Gianluigi Ferretti, Elisabetta Cretella, Lorenzo Gianni, Claudia Bighin, Angela Toss, Claudio Zamagni, Patrizia Vici, Costanza De Rossi, Antonio Russo, Giancarlo Bisagni, Antonio Frassoldati, Lucia Borgato, Anna Cariello, Claudia Cappelletti, Roberto Bordonaro, Saverio Cinieri, Alessandra Modena, Matteo Valerio, Maria Francesca Alvisi, Irene De Simone, Francesca Galli, Eliana Rulli, Anna Santoni, Fabrizio Nicolis
(2023).
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.
Cancers (Basel).
Maurizio Muscaritoli, Alessandra Modena, Matteo Valerio, Paolo Marchetti, Roberto Magarotto, Silvia Quadrini, Filomena Narducci, Giuseppe Tonini, Teresa Grassani, Luigi Cavanna, Camilla Di Nunzio, Chiara Citterio, Marcella Occelli, Antonia Strippoli, Bruno Chiurazzi, Antonio Frassoldati, Giuseppe Altavilla, Antonio Lucenti, Fabrizio Nicolis, Stefania Gori
(2023).
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study.
Cancers.
Chiara Piubelli, Matteo Valerio, Matteo Verzè, Fabrizio Nicolis, Carlotta Mantoan, Sonia Zamboni, Francesca Perandin, Eleonora Rizzi, Stefano Tais, Monica Degani, Sara Caldrer, Federico Giovanni Gobbi, Zeno Bisoffi, Stefania Gori
(2023).
Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments.
Front Oncol.
Alessandro Inno, Marta Peri, Monica Turazza, Giuseppe Bogina, Alessandra Modena, Alberto Massocco, Modestino Pezzella, Matteo Valerio, Rosario Mazzola, Laura Olivari, Fabrizia Severi, Giovanni Foti, Cristina Mazzi, Fabiana Marchetti, Gianluigi Lunardi, Matteo Salgarello, Antonio Russo, Stefania Gori
(2022).
The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapy.
Front Oncol.
Stefania Gori, Fabio Puglisi, Stefano Moroso, Alessandra Fabi, Nicla La Verde, Antonio Frassoldati, Emiliana Tarenzi, Ornella Garrone, Patrizia Vici, Lucio Laudadio, Elisabetta Cretella, Monica Turazza, Jennifer Foglietta, Vita Leonardi, Luigi Cavanna, Sandro Barni, Daniele Galanti, Antonio Russo, Fabiana Marchetti, Matteo Valerio, Gianluigi Lunardi, Filippo Alongi, Alessandro Inno
(2019).
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Clinical Breast Cancer.
Alessandro Vitale, Fabio Farinati, Giulia Noaro, Patrizia Burra, Timothy M. Pawlik, Laura Bucci, Edoardo G. Giannini, Chiara Faggiano, Francesca Ciccarese, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Roberto Virdone, Fabio Marra, Martina Felder, Filomena Morisco, Luisa Benvegnù, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Andrea Olivani, Alberto Masotto, Gerardo Nardone, Antonio Colecchia, Fabio Fornari, Massimo Marignani, Susanna Vicari, Emanuela Bortolini, Raffaele Cozzolongo, Alessandro Grasso, Camillo Aliberti, Mauro Bernardi, Anna Chiara Frigo, Mauro Borzio, Franco Trevisani, Umberto Cillo, Italian Liver Cancer (ITA. LI. CA) Group
(2018).
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study.
Hepatology.
Filomena Morisco, Maria Guarino, Maria Rosa Valvano, Francesco Auriemma, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Francesco Tovoli, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Luisa Benvengù, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Fabio Marra, Nicola Caporaso, Franco Trevisani, Italian Liver Cancer (ITA. LI. CA) Group
(2018).
Metabolic disorders across hepatocellular carcinoma in Italy.
Liver Int..
Edoardo G. Giannini, Laura Bucci, Francesca Garuti, Matteo Brunacci, Barbara Lenzi, Matteo Valente, Eugenio Caturelli, Giuseppe Cabibbo, Fabio Piscaglia, Roberto Virdone, Martina Felder, Francesca Ciccarese, Francesco Giuseppe Foschi, Rodolfo Sacco, Gianluca Svegliati-Baroni, Fabio Farinati, Gian Lodovico Rapaccini, Andrea Olivani, Antonio Gasbarrini, Maria Di Marco, Filomena Morisco, Marco Zoli, Alberto Masotto, Franco Borzio, Luisa Benvegnù, Fabio Marra, Antonio Colecchia, Gerardo Nardone, Mauro Bernardi, Franco Trevisani, Italian Liver Cancer (ITA. LI. CA) Group
(2017).
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Hepatology.
Anna Pecorelli, Barbara Lenzi, Annagiulia Gramenzi, Francesca Garuti, Fabio Farinati, Edoardo G. Giannini, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Filomena Morisco, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco G. Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Mauro Bernardi, Franco Trevisani, Italian LiverCancer (ITA. LI. CA) group
(2017).
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
Liver Int..
Giuseppe Cabibbo, Salvatore Petta, Marco Barbara, Simona Attardo, Laura Bucci, Fabio Farinati, Edoardo G. Giannini, Giulia Negrini, Francesca Ciccarese, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Roberto Virdone, Fabio Marra, Andrea Mega, Filomena Morisco, Luisa Benvegnù, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Andrea Olivani, Alberto Masotto, Gerardo Nardone, Antonio Colecchia, Marcello Persico, Antonio Craxì, Franco Trevisani, Calogero Cammà, Italian Liver Cancer (ITA. LI. CA) Group
(2017).
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
J. Hepatol..
S. Petta, G. Cabibbo, M. Barbara, S. Attardo, L. Bucci, F. Farinati, E. G. Giannini, F. Tovoli, F. Ciccarese, G. L. Rapaccini, M. Di Marco, E. Caturelli, M. Zoli, F. Borzio, R. Sacco, R. Virdone, F. Marra, M. Felder, F. Morisco, L. Benvegnù, A. Gasbarrini, G. Svegliati-Baroni, F. G. Foschi, A. Olivani, A. Masotto, G. Nardone, A. Colecchia, M. Persico, V. Boccaccio, A. Craxì, S. Bruno, F. Trevisani, C. Cammà, Italian Liver Cancer (ITA. LI. CA) Group
(2017).
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.
Aliment. Pharmacol. Ther..
Giuseppe Cabibbo, Salvatore Petta, Marco Barbara, Gabriele Missale, Roberto Virdone, Eugenio Caturelli, Fabio Piscaglia, Filomena Morisco, Antonio Colecchia, Fabio Farinati, Edoardo Giannini, Franco Trevisani, Antonio Craxì, Massimo Colombo, Calogero Cammà, ITA. LI. CA study group
(2017).
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.
Liver Int..
Laura Bucci, Francesca Garuti, Barbara Lenzi, Anna Pecorelli, Fabio Farinati, Edoardo G. Giannini, Alessandro Granito, Francesca Ciccarese, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Calogero Cammà, Roberto Virdone, Fabio Marra, Martina Felder, Filomena Morisco, Luisa Benvegnù, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Antonio Colecchia, Mauro Bernardi, Franco Trevisani, Italian Liver Cancer (ITA. LI. CA) Group
(2016).
The evolutionary scenario of hepatocellular carcinoma in Italy: an update.
Liver Int..
A. Cucchetti, F. Trevisani, L. Bucci, M. Ravaioli, F. Farinati, E. G. Giannini, F. Ciccarese, F. Piscaglia, G. L. Rapaccini, M. Di Marco, E. Caturelli, M. Zoli, F. Borzio, R. Sacco, M. Maida, M. Felder, F. Morisco, A. Gasbarrini, S. Gemini, F. G. Foschi, G. Missale, A. Masotto, A. Affronti, M. Bernardi, A. D. Pinna, Italian Liver Cancer Group
(2016).
Years of life that could be saved from prevention of hepatocellular carcinoma.
Aliment. Pharmacol. Ther..
Fabio Farinati, Alessandro Vitale, Gaya Spolverato, Timothy M. Pawlik, Teh-la Huo, Yun-Hsuan Lee, Anna Chiara Frigo, Anna Giacomin, Edoardo G. Giannini, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Rodolfo Sacco, Filomena Morisco, Elisabetta Biasini, Francesco Giuseppe Foschi, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Roberto Virdone, Alberto Masotto, Franco Trevisani, Umberto Cillo, ITA. LI. CA study group
(2016).
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
PLoS Med..
L. Bucci, F. Garuti, V. Camelli, B. Lenzi, F. Farinati, E. G. Giannini, F. Ciccarese, F. Piscaglia, G. L. Rapaccini, M. Di Marco, E. Caturelli, M. Zoli, F. Borzio, R. Sacco, M. Maida, M. Felder, F. Morisco, A. Gasbarrini, S. Gemini, F. G. Foschi, G. Missale, A. Masotto, A. Affronti, M. Bernardi, F. Trevisani, Italian Liver Cancer (ITA. LI. CA) Group, Italian Liver Cancer ITA LI CA Group
(2016).
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Aliment. Pharmacol. Ther..
Edoardo G. Giannini, Alessandro Moscatelli, Gaia Pellegatta, Alessandro Vitale, Fabio Farinati, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Rodolfo Sacco, Filomena Morisco, Gabriele Missale, Francesco Giuseppe Foschi, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Roberto Virdone, Alberto Masotto, Franco Trevisani, Italian Liver Cancer (ITA. LI. CA) Group, Italian Liver Cancer ITA LI CA Group
(2016).
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
Am. J. Gastroenterol..
A. Inno, G. Lunardi, M. Turazza, S. Pasetto, F. Severi, G. Gorgoni, G. Bogina, L. Bortesi, A. Russo, F. Alongi, A. Fiorentino, S. Duranti, A. Massocco, F. Marchetti, Matteo Valerio, M. Salgarello, S. Gori
(2015).
FDG-PET/CT as a predictor of pathological complete response (pCR) in breast cancer (BC) patients (pts) treated with neoadjuvant chemotherapy (NAC): a single center retrospective study.
Ann Oncol.
G. Lunardi, R. Magarotto, A. Inno, P. Cassandrini, M. Cirillo, S. Duranti, M. Nicodemo, V. Picece, M. Turazza, F. Marchetti, B. Micheloni, Matteo Valerio, L. Zenari, S. Gori
(2015).
Association between patient reported outcomes and vibratory perception threshold test for measuring neurotoxicity in patients with chemotherapy induced peripheral neuropathy.
Ann Oncol.
Giuseppe S. Bogina, Gianluigi Lunardi, Lisa Marcolini, Matteo Brunelli, Laura Bortesi, Marcella Marconi, Francesca Coati, Matteo Valerio, Massimo Guerriero, Alberto Massocco, Maria C. Pegoraro, Giuseppe Zamboni
(2014).
P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomas.
Mod. Pathol..